Trexquant Investment’s Beam Therapeutics BEAM Stock Holding History

Trexquant Investment’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$529K	Buy	+15,406	New	+$465K	﹤0.01%	1629
2025 Q4	–	Sell	-25,439	Closed	-$617K	–	1589
2025 Q3	$617K	Sell	25,439 -123,613	-83%	-$2.46M	0.01%	1272
2025 Q2	$2.54M	Buy	+149,052	New	+$2.6M	0.03%	804
2023 Q4	–	Sell	-14,952	Closed	-$360K	–	1430
2023 Q3	$360K	Buy	+14,952	New	+$401K	0.01%	1150
2023 Q2	–	Sell	-8,164	Closed	-$250K	–	1443
2023 Q1	$250K	Buy	8,164 +3,025	+59%	+$119K	0.01%	1261
2022 Q4	$201K	Sell	5,139 -17,095	-77%	-$766K	0.01%	1247
2022 Q3	$1.06M	Sell	22,234 -35,443	-61%	-$2.02M	0.04%	511
2022 Q2	$2.23M	Buy	57,677 +36,050	+167%	+$1.43M	0.1%	241
2022 Q1	$1.24M	Buy	+21,627	New	+$1.42M	0.06%	401
2021 Q4	–	Sell	-13,803	Closed	-$1.2M	–	1298
2021 Q3	$1.2M	Buy	13,803 +7,259	+111%	+$729K	0.1%	281
2021 Q2	$842K	Sell	6,544 -11,334	-63%	-$903K	0.07%	347
2021 Q1	$1.43M	Buy	17,878 +9,209	+106%	+$876K	0.13%	202
2020 Q4	$708K	Buy	+8,669	New	+$426K	0.08%	348

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Trexquant Investment's BEAM Position: Q2 2026 in Review

Trexquant Investment opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 15,406 shares worth $529K. The stake represents ﹤0.01% of the portfolio and ranks #1629 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in BEAM as recently as Q3 2025.

Trexquant Investment first reported a position in BEAM in Q4 2020 and has held it in 13 quarters since. The position peaked at $2.54M in Q2 2025. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Trexquant Investment held 15,406 shares of Beam Therapeutics worth $529K as of Q2 2026.
Beam Therapeutics was a new Trexquant Investment position in Q2 2026.
Beam Therapeutics made up ﹤0.01% of Trexquant Investment's portfolio in Q2 2026, its #1629 holding.
Trexquant Investment first reported a position in Beam Therapeutics in Q4 2020 and has held it in 13 quarters since.
Trexquant Investment's Beam Therapeutics position peaked at $2.54M in Q2 2025.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.